Johnson & Johnson announces a proposed settlement of up to US$5.5 billion to resolve ongoing lawsuits alleging that its talc-based baby powder and other talc products are linked to ovarian cancer. Multiple outlets report that the settlement is intended to end years of litigation brought by tens of thousands of claimants who say exposure to J&J’s talc caused cancer.

BBC Business and other sources describe the deal as a way to close the legal battle while providing compensation to affected plaintiffs. Reports also emphasize that the settlement is structured to require approval before it becomes final. Rappler specifically says the proposal must be accepted by 95% of ovarian cancer claimants in state or federal court for finalization, indicating that the agreement is subject to claimant approval.

Several outlets frame the amount as “up to” US$5.5 billion, suggesting payment levels may depend on the number and eligibility of claims resolved under the terms. The announcement follows continuing legal disputes over causation and product liability claims tied to talc products.